- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By 
Jeff Dale2023-06-09T15:20:00
The chief compliance officer of a defunct pharmacy holding company was found guilty of conspiracy to commit healthcare fraud and wire fraud Thursday for unnecessarily billing Medicare for more than $50 million in medical supplies.
Steven King, of Florida, was convicted by a federal jury for his misconduct at A1C Holdings, which ran pharmacies across several states, including Michigan-based All American Medical Pharmacy, the Department of Justice (DOJ) announced in a press release.
King, along with his alleged co-conspirators, exploited Medicare beneficiaries by billing for lidocaine and diabetic testing supplies that were neither required nor requested by patients. These actions defrauded Medicare and violated pharmacy benefit manager regulations, the DOJ stated.
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
Former executives of Medly, an online pharmacy that is now shuttered, have been charged by the Securities and Exchange Commission with defrauding investors.
The chief compliance officer of a defunct pharmacy holding company was sentenced to 4 1/2 years in prison after being found guilty of conspiracy to commit healthcare fraud and wire fraud earlier this year.
Tenet Healthcare, Vanguard Health Systems, and the Detroit Medical Center agreed to pay $29.7 million as part of a settlement with the Department of Justice addressing allegations they provided kickbacks to doctors who made referrals to their health organizations.
USAA Federal Savings Bank has been hit with its third cease and desist order from the Treasury Department’s Office of the Comptroller of the Currency in the past five years for failing to correct unsafe and unsound banking practices.
Becton Dickinson medical device company will pay $175 million for “repeatedly” misleading investors about its Alaris infusion pump, a product the company knew was flawed and was sold without the required patient-safety approvals, the Securities and Exchange Commission said.
The Securities and Exchange Commission charged bankrupt fashion retailer Express with failing to disclose nearly $1 million in perks to a former chief executive, but did not levy a financial penalty thanks to its cooperation, the SEC said.
